Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mauguen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|February 26, 2011
Dose-finding approach for dose escalation with overdose control considering incomplete observationsA Mauguen, M C Le Deley, S Zohar
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 28, 2012
Variation in the peritoneal cancer index scores between surgeons and according to when they are determined (before or after cytoreductive surgery)D Elias, A Souadka, F Fayard, et al.
Gynecologie, Obstetrique & Fertilite|April 19, 2011
[Survival and prognostic factors after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer]C Touboul, C Uzan, A Mauguen, et al.
BMC Medical Informatics and Decision Making|June 26, 2020
GUIP1: a R package for dose escalation strategies in phase I cancer clinical trialsD Dinart, J Fraisse, D Tosi, et al.
British Journal of Cancer|March 10, 2011
Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitorsF Farace, M Gross-Goupil, E Tournay, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|October 30, 2010
[Postoperative morbidity after completion surgery following homogeneous chemoradiation therapy in locally advanced cervical cancer]C Touboul, C Uzan, A Mauguen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2012
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancerJ-C Soria, A Mauguen, M Reck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2019
Correction to: <sup>18</sup>F-Fluciclovine (<sup>18</sup>F-FACBC) PET imaging of recurrent brain tumorsLaure Michaud, B J Beattie, T Akhurst, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2019
<sup>18</sup>F-Fluciclovine (<sup>18</sup>F-FACBC) PET imaging of recurrent brain tumorsLaure Michaud, B J Beattie, T Akhurst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2012
Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancerF Andre, R Conforti, C B Moeder, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|February 26, 2011
Dose-finding approach for dose escalation with overdose control considering incomplete observationsA Mauguen, M C Le Deley, S Zohar
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 28, 2012
Variation in the peritoneal cancer index scores between surgeons and according to when they are determined (before or after cytoreductive surgery)D Elias, A Souadka, F Fayard, et al.
Gynecologie, Obstetrique & Fertilite|April 19, 2011
[Survival and prognostic factors after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer]C Touboul, C Uzan, A Mauguen, et al.
BMC Medical Informatics and Decision Making|June 26, 2020
GUIP1: a R package for dose escalation strategies in phase I cancer clinical trialsD Dinart, J Fraisse, D Tosi, et al.
British Journal of Cancer|March 10, 2011
Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitorsF Farace, M Gross-Goupil, E Tournay, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|October 30, 2010
[Postoperative morbidity after completion surgery following homogeneous chemoradiation therapy in locally advanced cervical cancer]C Touboul, C Uzan, A Mauguen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2012
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancerJ-C Soria, A Mauguen, M Reck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2019
Correction to: <sup>18</sup>F-Fluciclovine (<sup>18</sup>F-FACBC) PET imaging of recurrent brain tumorsLaure Michaud, B J Beattie, T Akhurst, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2019
<sup>18</sup>F-Fluciclovine (<sup>18</sup>F-FACBC) PET imaging of recurrent brain tumorsLaure Michaud, B J Beattie, T Akhurst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2012
Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancerF Andre, R Conforti, C B Moeder, et al.
Pageof 2